Clinical Trial Update: A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 safety study comparing spray 188-0551 to the reference listed drug in adults with plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• 188-0551 spray
• Reference Listed Drug

Snippet

Sponsor: Therapeutics, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED